Pediatrics, Pediatric Hematology-Oncology · Greenville, SC
NPI
1124175146
Since 2007
Specialty
Pediatrics, Pediatric Hematology-Oncology
Code 2080P0207X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
900 W Faris Rd, 2nd Floor
Greenville, SC, 29605
Phone (864) 455-8898
Groups this clinician bills Medicare through
Medicare paid, 2024
$8,276
96 services
Medicare patients, 2024
26
Average age 41
Drug cost, 2024
$717K
985 prescriptions
Company payments, 2025
$31K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan R Anderson was code 99215 (office e&m - established), 73 times for 24 patients. In total Alan R Anderson billed 96 services in 4 codes, and Medicare paid $8,276.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 73 | 24 | $97.57 | $7,123 |
By year: 2022 $15K for 154 services; 2023 $11K for 110 services; 2024 $8,276 for 96 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alan R Anderson prescribed most often to Medicare patients was Oxycodone Hcl, with 113 prescriptions and refills. In total Alan R Anderson wrote 985 Medicare prescriptions that cost $717K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 113 | 113 | 20 | $2,956 |
| Hydromorphone Hcl Generic | 70 | 70 | Under 11 | $1,774 |
| Morphine Sulfate Er Morphine Sulfate | 68 | 68 | 16 | $3,260 |
| Cyclobenzaprine Hcl Generic | 67 | 67 | 19 | $400 |
| Hydroxyurea Generic | 44 | 82 | 15 | $746 |
| Deferasirox Generic | 42 | 42 | Under 11 | $72K |
| Methadone Hcl Generic | 38 | 38 | Under 11 | $829 |
| Oxbryta Voxelotor | 35 | 35 | 13 | $422K |
| Gabapentin Generic | 31 | 33 | Under 11 | $359 |
| Promethazine Hcl Generic | 28 | 28 | Under 11 | $434 |
| Oxycontin Oxycodone Hcl | 28 | 28 | Under 11 | $35K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 27 | 27 | Under 11 | $327 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | Under 11 | $676 |
| Endari Glutamine | 21 | 21 | Under 11 | $61K |
| Buprenorphine Generic | 21 | 21 | Under 11 | $6,007 |
Brand drugs: 176 claims; generic drugs: 809 claims; opioid claims: 401.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan R Anderson $31K ($24K in general payments such as food, travel and fees and $6,730 for research) from 10 companies. The largest payer was Pfizer Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 12 | $22K |
| Agios Pharmaceuticals, Inc. AGIO | 13 | $8,519 |
| CSL Behring CSL.AX | 2 | $53.66 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $42.91 |
| Adaptive Biotechnologies Corporation ADPT | 1 | $33.77 |
| Novo Nordisk Inc NVO | 1 | $24.4 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $21.95 |
| Rare Disease Therapeutics, Inc. | 1 | $18.61 |
| Y-mAbs Therapeutics, Inc. | 1 | $17.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.